Event: Vii Nutrition x UPM Collaboration Opening Ceremony
Time: 10.15 am (tentative)
Date: 22nd December 2020 (Tuesday)
PC Venue: Ballroom, Double Tree Hotel, KL
PNT Research Vii Nutrition collaboration with University Putra Malaysia (UPM), Bioprocessing and Biomanufacturing Research Centre (BBRC) work on enhance the efficacy of functional ingredients to contribute towards a society with healthy ageing. The collaboration will delve into the huge potential microalgae bring in preventing oxidative stress.
Oxidative stress had been linked to many chronic diseases, such as cancer, diabetics, Alzheimer’s disease and cardiovascular diseases (CVDs). Oxidative stress is caused by an excess of free radicals in the body’s cells and can damage cells, proteins, and DNA. It leads to premature ageing and is increasingly common due to many factors including ageing, lifestyle changes, stress and pollution.
BBRC team to study marine micro-algae TetraSOD®, which is touted as the most potent antioxidant and nutritious marine micro-algae functional ingredient.
“The world population is ageing, and Malaysia is no exception. As patriotic citizens, we want to contribute back to the community, starting with TetraSOD®. Our work will be built on a foundation of serious science, with the best interest of academia, industry and consumers in mind,” PNT Research managing director, Lee Bin Hao said.
let’s wait for their new product launch which I believe can brings a brand new horizon to our society and community.
About PNT Research
PNT Research is a science-driven functional ingredients and nutraceuticals R&D company. Simply put, our goal is to make health and wellness work. We stand out from the competition by having a full-fledged R&D team. From the start, PNT Research is about making premium functional ingredients and nutraceutic accessible to consumers. At the same time, we contribute towards sustainability and positive socio-economic impact.
Our regional and global partnerships are a reflection of our commitment to excellence in functional ingredients and nutraceuticals R&D. PNT Research is a subsidiary of Vii Biohealth Sciences, a biotech conglomerate headquartered in Madrid, Spain.
About Fitoplancton Marino
The mission of Fitoplancton Marino is to research, develop and supply microalgae-based products and functional ingredients that contribute to improve the good health and quality of life to consumers. Fitoplancton Marino developed TetraSOD® to increase physiological response against oxidative stress to aid performance and recovery, especially for athletes and people with an active lifestyle. The company is headquartered in Spain.
TetraSOD® is the most complete and comprehensive ingredient for the Healthy Ageing nutraceutical category. As we age, the production of SOD in our body decreases. TetraSOD® is the most concentrated SOD source in the market. SOD, catalase (CAT) and glutathione peroxidase (GPx) are the primary protectors of cells against oxidative stress, which is the leading cause of ageing. TetraSOD® also induces redox homeostasis, which is necessary for the maintenance of many cellular processes, including oxidation-reduction reactions. TetraSOD® also activates NF-E2–related factor 2 (Nrf2), which is the antioxidant response pathway in human cells.
DKSH is the leading Market Expansion Services provider with a focus on Asia. The Group helps companies to grow across the Business Units Healthcare, Consumer Goods, Performance Materials and Technology. The service portfolio covers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Publicly listed on the SIX Swiss Exchange, the Group operates in 36 markets with 33,350 specialists, generating net sales of CHF 11.6 billion in 2019. With its Swiss heritage, DKSH has been deeply rooted in Asia Pacific since 1865. The DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care and various industrial applications. With 46 innovation centers and regulatory support worldwide, we create cutting-edge formulations that comply with local regulations. With around 1,100 specialists, the Business Unit generated net sales of CHF 1.0 billion in 2019.
The GELITA Group is the global market leader, producing collagen proteins in 23 factories across all the continents, especially for use in the manufacture of food and pharmaceuticals and in technical applications, as well as collagen peptides for the joint pain treatment, weight reduction and cosmetics markets. The group’s headquarters are in Eberbach in Germany. In 2019 the group had a workforce of 2,500 and a global turnover of EUR 749 million. Gelita’s Verisol is composed of pure collagen peptides that have been specially developed to provide the highest possible efficacy in human skin. They stimulate fibroblast cells in the dermis, which substantially increases the renewal and repair of collagen, elastin and proteoglycans – all of which are essential for providing skin elasticity. As a result, the epidermis is supported from within and skin sagging is prevented.